Oxford Immunotec Global PLC (NASDAQ:OXFD)

12.13
Delayed Data
As of Feb 23
 +0.17 / +1.42%
Today’s Change
10.00
Today|||52-Week Range
19.51
-13.17%
Year-to-Date
No recent news for Oxford Immunotec Global PLC.

Today’s Trading

Previous close11.96
Today’s open12.05
Day’s range11.80 - 12.21
Volume59,865
Average volume (3 months)187,129
Market cap$311.2M
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+10.71%
Earnings growth (this year)-114.72%
Earnings growth (next 5 years)--
Revenue growth (last year)+37.11%
P/E ratioNM
Price/Sales3.88
Price/Book3.76

Competitors

 Today’s
change
Today’s
% change
CLDXCelldex Therapeutics...+0.01+0.42%
VCYTVeracyte Inc+0.07+1.23%
CALACalithera Bioscience...-0.05-0.62%
VIVOMeridian Bioscience ...+0.05+0.36%
Data as of 4:00pm ET, 02/23/2018

Financials

Last reporting date--
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$86.1M
Annual profit (last year)-$22.3M
Net profit margin-25.96%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Executive Director
Peter James Wrighton-Smith
Chief Operating Officer
Stefan C. Linn
Corporate headquarters
Abingdon, Oxfordshire

Forecasts